Get the Stockscreener App
0.8137
2.90%
-0.0243
After Hours:
.81
-0.0037
-0.45%
Pasithea Therapeutics Corp stock is traded at $0.8137, with a volume of 204.96K.
It is down -2.90% in the last 24 hours and up +11.19% over the past month.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
See More
Previous Close:
$0.838
Open:
$0.8229
24h Volume:
204.96K
Relative Volume:
1.78
Market Cap:
$6.06M
Revenue:
-
Net Income/Loss:
$-16.28M
P/E Ratio:
-0.0585
EPS:
-13.91
Net Cash Flow:
$-13.75M
1W Performance:
+13.28%
1M Performance:
+11.19%
6M Performance:
-50.98%
1Y Performance:
-78.56%
1-Day Range:
$0.723
$0.838
1-Week Range:
$0.691
$0.84
52-Week Range:
$0.65
$4.35
Pasithea Therapeutics Corp Stock (KTTA) Company Profile
Name
Pasithea Therapeutics Corp
Sector
Industry
Phone
(702) 514-4174
Address
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH
Compare KTTA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KTTA
Pasithea Therapeutics Corp
|
0.8137 | 6.24M | 0 | -16.28M | -13.75M | -13.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | -52.09M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Pasithea Therapeutics Corp Stock (KTTA) Latest News
Backtesting results for Pasithea Therapeutics Corp. Equity Warrant trading strategies2025 Short Interest & Growth Oriented Trading Recommendations - newser.com
Will Pasithea Therapeutics Corp. stock outperform tech sector in 2025Bear Alert & Community Consensus Picks - newser.com
Will Pasithea Therapeutics Corp. Equity Warrant stock outperform value stocksWeekly Investment Report & AI Enhanced Trade Execution Alerts - newser.com
What institutional flow reveals about Pasithea Therapeutics Corp. Equity WarrantIndex Update & Risk Controlled Daily Trade Plans - newser.com
Is Pasithea Therapeutics Corp. stock cheap compared to fundamentals2025 Retail Activity & Long-Term Growth Stock Strategies - newser.com
Can Pasithea Therapeutics Corp. stock outperform in 2025 bull market2025 Volume Leaders & Technical Analysis for Trade Confirmation - newser.com
Is it too late to sell Pasithea Therapeutics Corp.CEO Change & Daily Stock Trend Reports - newser.com
Is Pasithea Therapeutics Corp. Equity Warrant stock positioned for long term growthWeekly Profit Recap & Reliable Volume Spike Trade Alerts - newser.com
Is Pasithea Therapeutics Corp. reversing from oversold territory2025 Winners & Losers & Low Risk Entry Point Guides - newser.com
Can Pasithea Therapeutics Corp. stock attract ESG capital inflowsDividend Hike & Weekly Momentum Picks - newser.com
Real time social sentiment graph for Pasithea Therapeutics Corp. Equity WarrantOptions Play & High Win Rate Trade Alerts - newser.com
Does Pasithea Therapeutics Corp. Equity Warrant qualify in momentum factor screening2025 Key Lessons & Risk Controlled Stock Alerts - newser.com
Pasithea Therapeutics Corp. stock chart pattern explained2025 Dividend Review & Community Shared Stock Ideas - newser.com
Is Pasithea Therapeutics Corp. stock a buy for dividend growthWeekly Gains Report & AI Driven Price Forecasts - newser.com
Has Pasithea Therapeutics Corp. formed a bullish divergenceMarket Sentiment Review & Free High Return Stock Watch Alerts - newser.com
Chart based analysis of Pasithea Therapeutics Corp. Equity Warrant trendsForecast Cut & Precise Buy Zone Identification - newser.com
Short interest data insights for Pasithea Therapeutics Corp.Portfolio Gains Summary & Technical Confirmation Trade Alerts - newser.com
Is Pasithea Therapeutics Corp. stock a safe investment in uncertain marketsJuly 2025 Volume & Smart Investment Allocation Insights - newser.com
Pasithea Therapeutics Corp Equity Warrant Stock Analysis and ForecastPrice Support Zones & Get Mentorship from Elite Traders - earlytimes.in
Comparing Pasithea Therapeutics Corp. Equity Warrant in custom built stock radarsJuly 2025 Sector Moves & AI Driven Stock Movement Reports - newser.com
Why retail investors pile into Pasithea Therapeutics Corp. Equity Warrant stockJuly 2025 Highlights & Technical Entry and Exit Alerts - newser.com
Is Pasithea Therapeutics Corp. Equity Warrant stock supported by strong cash flowsWeekly Trade Analysis & Verified Momentum Stock Alerts - newser.com
Should you hold or exit Pasithea Therapeutics Corp. Equity Warrant nowCEO Change & Verified Short-Term Plans - newser.com
Will Pasithea Therapeutics Corp. Equity Warrant stock continue dividend increasesWeekly Risk Report & AI Powered Trade Plan Recommendations - newser.com
How Pasithea Therapeutics Corp. Equity Warrant stock trades during market volatilityQuarterly Trade Review & Daily Risk Controlled Trade Plans - newser.com
Pasithea Therapeutics Corp. Equity Warrant stock daily chart insightsWeekly Loss Report & Technical Analysis for Trade Confirmation - newser.com
Pasithea Therapeutics Corp. Equity Warrant stock trend forecastShare Buyback & Free Reliable Trade Execution Plans - newser.com
Multi factor analysis applied to Pasithea Therapeutics Corp.July 2025 Catalysts & Weekly High Momentum Picks - newser.com
Pasithea Therapeutics Corp. Equity Warrant stock trend outlook and recovery pathWeekly Profit Recap & Accurate Intraday Trade Tips - newser.com
Is Pasithea Therapeutics Corp. stock a dividend growth opportunityJuly 2025 PreEarnings & Stepwise Entry and Exit Trade Signals - newser.com
Can swing trading help recover from Pasithea Therapeutics Corp. losses2025 Macro Impact & Low Drawdown Momentum Ideas - newser.com
Why Pasithea Therapeutics Corp. stock is favored by top institutionsJuly 2025 Patterns & Free Fast Entry Momentum Trade Alerts - newser.com
Using data tools to time your Pasithea Therapeutics Corp. Equity Warrant exit2025 Price Momentum & Consistent Income Trade Ideas - newser.com
Pasithea Therapeutics Corp Stock (KTTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Pasithea Therapeutics Corp Stock (KTTA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Marques Tiago | Chief Executive Officer |
May 12 '25 |
Sale |
0.82 |
960 |
792 |
40,001 |
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):